Management and Long-Term Outcome of Acute Coronary Syndrome Patients Presenting with Heart Failure in a Contemporary New Zealand Cohort (ANZACS-QI 4)

详细信息    查看全文

• 作者：Shaw Hua (Anthony) Kueh ; MBChB^a ; Gerry Devlin ; MBChB^b ; Mildred Lee ; MSc^a ; Rob N. Doughty ; MBChB^c ; Andrew J. Kerr ; MBChB^a ; ^d ; ^{Andrew.Kerr@middlemore.co.nz" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Heart failure ; Cardiomyopathy ; Acute coronary syndrome ; Myocardial infarction ; Treatment outcome
• 刊名：Heart, Lung and Circulation
• 出版年：2016
• 出版时间：August 2016
• 年：2016
• 卷：25
• 期：8
• 页码：837-846
• 全文大小：568 K

文摘

Acute heart failure (HF) associated with an acute coronary syndrome (ACS) predicts adverse outcome. There have been important recent improvements in ACS management. Our aim was to describe the management and outcomes in those with and without HF in a contemporary ACS cohort.

Methods

Consecutive patients presenting with ACS between 2007 and 2011 were enrolled in the All New Zealand Acute Coronary Syndrome Quality Improvement (ANZACS-QI) registry. Outcomes and medication dispensing were obtained using anonymised linkage to national data sets. A summary pharmacotherapy measure of “quadruple therapy” was defined as dispensing of at least one agent from each of the four evidence-based classes – anti-platelet, statin, angiotensin converting enzyme inhibitor/angiotensin receptor blocker and beta blocker.

Results

Of 3743 ACS patients 14% had acute HF. Acute heart failure patients were older (69.2±12.6 vs 62.3±12.8 years, p < 0.001), less likely to have coronary angiography (66% vs 86%, p<0.001) and revascularisation (46% vs 62%, p<0.001). Immediate post-discharge quadruple therapy was higher for those with than without HF (61% vs 55%, p=0.02) but fell to similar levels by one-year (45% vs 53%, p=0.55). At four years follow-up nearly half of those presenting with ACS and HF had died. After adjustment, HF remained a strong predictor of death within 28 days (OR 2.9, 95%CI 1.5 – 5.5) and beyond 28 days (HR 1.8, 95%CI 1.5 – 2.3).

Conclusion

Acute heart failure complicating ACS is associated with heightened risk of short-term and long-term mortality. One in three ACS patients with HF did not have coronary angiography and less than half received quadruple therapy a year after presentation.